ATE331502T1 - 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette - Google Patents

4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Info

Publication number
ATE331502T1
ATE331502T1 AT01949210T AT01949210T ATE331502T1 AT E331502 T1 ATE331502 T1 AT E331502T1 AT 01949210 T AT01949210 T AT 01949210T AT 01949210 T AT01949210 T AT 01949210T AT E331502 T1 ATE331502 T1 AT E331502T1
Authority
AT
Austria
Prior art keywords
hydroxybutylidene
amino
tablet containing
compressed tablet
direct compressed
Prior art date
Application number
AT01949210T
Other languages
English (en)
Inventor
Dagmar Jasprova
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE331502(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE331502T1 publication Critical patent/ATE331502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01949210T 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette ATE331502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20002567A CZ289261B6 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby

Publications (1)

Publication Number Publication Date
ATE331502T1 true ATE331502T1 (de) 2006-07-15

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949210T ATE331502T1 (de) 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Country Status (17)

Country Link
US (1) US7198802B2 (de)
EP (1) EP1299088B1 (de)
AT (1) ATE331502T1 (de)
AU (1) AU2001270454A1 (de)
BG (1) BG107520A (de)
CA (1) CA2415630A1 (de)
CZ (1) CZ289261B6 (de)
DE (1) DE60121166D1 (de)
EE (1) EE200300017A (de)
HR (1) HRP20020735A2 (de)
HU (1) HUP0301072A3 (de)
PL (1) PL360872A1 (de)
RU (1) RU2279273C2 (de)
SK (1) SK283249B6 (de)
UA (1) UA73784C2 (de)
WO (1) WO2002003963A1 (de)
YU (1) YU77702A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
EP1499295A4 (de) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co Metoprolol-formulierungen mit verzögerter freisetzung
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
EP1781258A1 (de) * 2004-08-20 2007-05-09 Mepha AG Formulierungen von biphosphonaten
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
ES2507552T3 (es) * 2005-10-27 2014-10-15 Nexilis Ag Implante que contiene amino-bisfosfonatos y procedimiento para su producción
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20110229566A1 (en) * 2008-08-22 2011-09-22 Yatendra Kumar Gupta Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof
EA201190243A1 (ru) * 2009-05-19 2013-01-30 Гриндекс, Э Джоинт Сток Кампани Стабильная фармацевтическая композиция флударабина фосфата
DK2512455T3 (en) 2009-12-18 2014-03-24 Frieslandcampina Nederland Holding B V Co-treated tablet adjuvant composition, its preparation and use
CN117835971A (zh) 2021-08-25 2024-04-05 巴斯夫欧洲公司 直接压片用辅料组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US5650168A (en) * 1993-05-15 1997-07-22 Boehringer Mannheim Gmbh Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
NZ517472A (en) 1997-03-26 2003-08-29 Sepracor Inc Lactose free norastemizole formulations with improved stability
CA2405070A1 (en) * 2000-04-07 2001-10-18 Pfizer Products Inc. Estrogen agonist/antagonist metabolites

Also Published As

Publication number Publication date
PL360872A1 (en) 2004-09-20
CZ20002567A3 (cs) 2001-12-12
YU77702A (sh) 2006-05-25
UA73784C2 (en) 2005-09-15
DE60121166D1 (de) 2006-08-10
HRP20020735A2 (en) 2004-12-31
EE200300017A (et) 2004-10-15
CZ289261B6 (cs) 2001-12-12
HUP0301072A2 (hu) 2003-08-28
US7198802B2 (en) 2007-04-03
EP1299088A1 (de) 2003-04-09
CA2415630A1 (en) 2002-01-17
SK283249B6 (sk) 2003-04-01
SK5112001A3 (en) 2002-02-05
AU2001270454A1 (en) 2002-01-21
BG107520A (bg) 2003-06-30
US20030161878A1 (en) 2003-08-28
HUP0301072A3 (en) 2005-07-28
EP1299088B1 (de) 2006-06-28
RU2279273C2 (ru) 2006-07-10
WO2002003963A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
NZ507271A (en) Fast disintegrating tablets
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
DK0996429T3 (da) Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
TNSN04213A1 (en) High drug load tablet
CY1110988T1 (el) Ταχεως αποσαθρουμενο στερεο παρασκευασμα
JP2002511411A5 (de)
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ATE331502T1 (de) 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CA2326222A1 (en) Medicinal compositions
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
CA2326339A1 (en) Use of dexmedetomidine for icu sedation
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
FI891865A0 (fi) Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
MXPA03001081A (es) Medicamento anti-inflamatorio.
CA2311024A1 (en) Pharmaceutical composition for oral administration of chelating agents
BRPI9916820B8 (pt) composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método
EP1219296A4 (de) Mittel zur hemmung der sebumproduktion
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties